SCHEMBL4154125

SCHEMBL4154125

O=C(N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)Nc1cc(Cl)cc(Cl)c1)c1ccc2nccnc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 1/20 0.41
PADI2 Q9Y2J8 1/20 0.41
NPC1 O15118 9/20 0.40
RAB9A P51151 9/20 0.40
KMT2A Q03164 6/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 5/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 2/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HDAC1 Q13547 3/20 0.37
POLB P06746 2/20 0.35
GAA P10253 1/20 0.35
MAPK14 Q16539 1/20 0.34
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4165005 0.86 ALDH1A1 (0.41) PADI4PADI2NPC1RAB9AKMT2A
SCHEMBL4168646 0.86 HDAC1 (0.48) PADI4PADI2NPC1RAB9AKMT2A
SCHEMBL4159631 0.84 HDAC4 (0.47) KMT2AALDH1A1MEN1MAPTHTT
SCHEMBL4156708 0.82 CCKBR (0.34) KMT2AMEN1HDAC1MAPK14CCKBR
SCHEMBL3507605 0.78 GPR139 (0.42) KMT2AMEN1HTTHDAC1GAA
SCHEMBL4605614 0.77 CES1 (0.45) RAB9AKMT2AALDH1A1MEN1MAPT
SCHEMBL4164039 0.77 HDAC1 (0.41) KMT2AALDH1A1MEN1HDAC1POLB
SCHEMBL4166182 0.76 PADI4 (0.48) PADI4PADI2NPC1RAB9AALDH1A1
SCHEMBL4153988 0.75 L3MBTL1 (0.47) PADI4PADI2KMT2AALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL4166937 0.74 FABP4 (0.36) KMT2AALDH1A1MEN1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 PADI4 374/4885PADI2 495/4885NPC1 1625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.